药品名称ASELLACRIN 2
申请号017726产品号002
活性成分SOMATROPIN市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格2 IU/VIAL
治疗等效代码参比药物
批准日期1983/07/21申请机构SERONO LABORATORIES INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
017726037AP1984/12/20Labeling Revision
017726035AP1984/12/20Manufacturing Change or Addition
017726034AP1984/12/20Labeling Revision
017726032AP1984/06/22Labeling Revision
017726031AP1984/06/22Labeling Revision
017726030AP1983/07/18Control Supplement
017726028AP1983/01/11Control Supplement
017726027AP1983/07/21Control Supplement
017726026AP1983/07/21Labeling Revision
017726025AP1983/07/21Control Supplement
017726024AP1982/03/12Labeling Revision
017726023AP1982/09/15Package Change
017726022AP1982/07/29Manufacturing Change or Addition
017726020AP1981/09/28Control Supplement
017726019AP1981/09/21Control Supplement
017726017AP1983/07/21Manufacturing Change or Addition
017726016AP1983/07/21Labeling Revision
017726015AP1981/04/09Expiration Date Change
017726014AP1980/11/28Distributor
017726013AP1980/11/28Manufacturing Change or Addition
017726012AP1980/07/21Labeling Revision
017726006AP1980/02/21Control Supplement
017726005AP1978/07/19Control Supplement
017726004AP1978/07/19Labeling Revision
017726003AP1978/07/19Distributor
017726002AP1978/07/19Control Supplement
017726001AP1979/01/23Manufacturing Change or Addition
017726000AP1976/07/30Approval